Tech Company Financing Transactions

Vasogenix Pharmaceuticals Funding Round

Vasogenix Pharmaceuticals, operating out of Lenexa, secured $300 thousand from Kansas Technology Enterprise Corporation.

Transaction Overview

Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8527 Bluejacket Street
Lenexa, KS 66214
USA
Email Address
Not Recorded
Overview
VasoGenix Pharmaceuticals, Inc., is developing intravenous (IV) and controlled release drug treatments for addressing Heart Failure (HF) and other cardiac diseases in order to reduce the recurrence of these diseases and their resulting hospital and medical costs.
Profile
Vasogenix Pharmaceuticals LinkedIn Company Profile
Social Media
Vasogenix Pharmaceuticals Company Twitter Account
Company News
Vasogenix Pharmaceuticals News
Facebook
Vasogenix Pharmaceuticals on Facebook
YouTube
Vasogenix Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lee Southard
  Lee Southard LinkedIn Profile  Lee Southard Twitter Account  Lee Southard News  Lee Southard on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2008: Ception Therapeutics venture capital transaction
Next: 12/31/2008: Advanced Inquiry Systems venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary